Inspire Medical Systems has appointed Matt Osberg as Executive Vice President and Chief Financial Officer, effective January ...

Inspire Medical Systems’ growth strategy is focused on ensuring strong clinical outcomes, driving manufacturing capabilities, ...

Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

We came across a bullish thesis on Inspire Medical Systems, Inc. on Business Invest’s Substack by Francesco Ferrari. In this ...

Inspire Medical Systems, Inc. (NYSE:INSP) ranks among the best medical device stocks to invest in. On October 10, Inspire Medical Systems, Inc. (NYSE:INSP) published clinical data demonstrating the ...

In the fall of last year, I believed that the risk-reward proposition for Inspire Medical (INSP) was improving after shares were lagging, the business became profitable and the FDA granted approval ...

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...

Revenue for full year 2025 is anticipated to be in the range of $940 million to $955 million, a 17% to 19% increase over full year 2024 “We are very pleased with our strong preliminary revenue ...

Inspire Medical Systems is a rapidly growing medical technology company specializing in a device that treats Obstructive Sleep Apnea. The company is still in the early stages of developing their ...

Inspire Medical Systems appoints Dr. Paul Hoff and Dr. Ruchir Patel as Vice President, Senior Medical Directors to enhance OSA treatment. Inspire Medical Systems, Inc. announced the appointment of two ...